BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 22433824)

  • 1. Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.
    Thompson G; Mills SJ; Coope DJ; O'Connor JP; Jackson A
    Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S127-44. PubMed ID: 22433824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of imaging biomarkers. Part 3. The neuro-oncologist's perspective.
    Shenoy A
    Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S209-12. PubMed ID: 22433830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applications of imaging biomarkers. Part 2. The neurosurgeon's perspective.
    Brodbelt A
    Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S205-8. PubMed ID: 22433829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of tumor angiogenesis: functional or targeted?
    Turkbey B; Kobayashi H; Ogawa M; Bernardo M; Choyke PL
    AJR Am J Roentgenol; 2009 Aug; 193(2):304-13. PubMed ID: 19620425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of registration and fusion of multimodality brain images from PET, SPECT, CT, and MRI.
    Pietrzyk U; Herholz K; Schuster A; von Stockhausen HM; Lucht H; Heiss WD
    Eur J Radiol; 1996 Feb; 21(3):174-82. PubMed ID: 8777907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.
    Waerzeggers Y; Ullrich RT; Monfared P; Viel T; Weckesser M; Stummer W; Schober O; Winkeler A; Jacobs AH
    Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S179-95. PubMed ID: 22433828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in assessing glioblastoma microvasculature.
    Jia ZZ; Shi W; Shi JL; Shen DD; Gu HM; Zhou XJ
    Eur J Radiol; 2017 Feb; 87():120-124. PubMed ID: 28034567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre imaging measurements for oncology and in the brain.
    Tofts PS; Collins DJ
    Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S213-26. PubMed ID: 22433831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment.
    Cuenod CA; Fournier L; Balvay D; Guinebretière JM
    Abdom Imaging; 2006; 31(2):188-93. PubMed ID: 16447089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced imaging techniques: CT and MRI.
    O'Connor JP; Tofts PS; Miles KA; Parkes LM; Thompson G; Jackson A
    Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S112-20. PubMed ID: 22433822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive imaging for studying anti-angiogenic therapy effects.
    Ehling J; Lammers T; Kiessling F
    Thromb Haemost; 2013 Mar; 109(3):375-90. PubMed ID: 23407722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging in epilepsy.
    Salmenpera TM; Duncan JS
    J Neurol Neurosurg Psychiatry; 2005 Sep; 76 Suppl 3(Suppl 3):iii2-iii10. PubMed ID: 16107387
    [No Abstract]   [Full Text] [Related]  

  • 13. Imaging of brain tumors: perfusion/permeability.
    Thompson G; Mills SJ; Stivaros SM; Jackson A
    Neuroimaging Clin N Am; 2010 Aug; 20(3):337-53. PubMed ID: 20708550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches for imaging tumour responses to treatment.
    Brindle K
    Nat Rev Cancer; 2008 Feb; 8(2):94-107. PubMed ID: 18202697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives.
    O'Connor JP; Jackson A; Asselin MC; Buckley DL; Parker GJ; Jayson GC
    Lancet Oncol; 2008 Aug; 9(8):766-76. PubMed ID: 18672212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging tumor angiogenesis: functional assessment using MDCT or MRI?
    Goh V; Padhani AR
    Abdom Imaging; 2006; 31(2):194-9. PubMed ID: 16333695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroimaging in brain tumors].
    Arbizu J; Domínguez PD; Diez-Valle R; Vigil C; García-Eulate R; Zubieta JL; Richter JA
    Rev Esp Med Nucl; 2011; 30(1):47-65. PubMed ID: 21211868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to multimodality imaging of angiogenesis.
    Dobrucki LW; de Muinck ED; Lindner JR; Sinusas AJ
    J Nucl Med; 2010 May; 51 Suppl 1():66S-79S. PubMed ID: 20457795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomography and magnetic resonance features of extraventricular neurocytoma: a study of eight cases.
    Huang WY; Zhang BY; Geng DY; Zhang J
    Clin Radiol; 2013 Apr; 68(4):e206-12. PubMed ID: 23332437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis.
    Drevs J; Schneider V
    J Intern Med; 2006 Dec; 260(6):517-29. PubMed ID: 17116002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.